biote Statistics
Total Valuation
biote has a market cap or net worth of $158.78 million. The enterprise value is $239.23 million.
Important Dates
The next confirmed earnings date is Wednesday, March 12, 2025, after market close.
| Earnings Date | Mar 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
biote has 36.33 million shares outstanding. The number of shares has increased by 71.05% in one year.
| Current Share Class | 31.11M |
| Shares Outstanding | 36.33M |
| Shares Change (YoY) | +71.05% |
| Shares Change (QoQ) | -2.45% |
| Owned by Insiders (%) | 28.41% |
| Owned by Institutions (%) | 48.86% |
| Float | 15.29M |
Valuation Ratios
The trailing PE ratio is 20.00 and the forward PE ratio is 7.88.
| PE Ratio | 20.00 |
| Forward PE | 7.88 |
| PS Ratio | 0.74 |
| Forward PS | 0.69 |
| PB Ratio | -1.22 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 4.40 |
| P/OCF Ratio | 3.90 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 5.87, with an EV/FCF ratio of 6.79.
| EV / Earnings | 33.28 |
| EV / Sales | 1.24 |
| EV / EBITDA | 5.87 |
| EV / EBIT | 5.99 |
| EV / FCF | 6.79 |
Financial Position
The company has a current ratio of 1.50
| Current Ratio | 1.50 |
| Quick Ratio | 1.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.96 |
| Debt / FCF | 3.47 |
| Interest Coverage | 4.28 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 19.89% |
| Return on Invested Capital (ROIC) | 82.50% |
| Return on Capital Employed (ROCE) | 72.96% |
| Revenue Per Employee | $995,155 |
| Profits Per Employee | $37,052 |
| Employee Count | 194 |
| Asset Turnover | 1.54 |
| Inventory Turnover | 3.01 |
Taxes
In the past 12 months, biote has paid $2.93 million in taxes.
| Income Tax | 2.93M |
| Effective Tax Rate | 25.32% |
Stock Price Statistics
The stock price has decreased by -31.04% in the last 52 weeks. The beta is 1.04, so biote's price volatility has been similar to the market average.
| Beta (5Y) | 1.04 |
| 52-Week Price Change | -31.04% |
| 50-Day Moving Average | 5.41 |
| 200-Day Moving Average | 6.09 |
| Relative Strength Index (RSI) | 35.20 |
| Average Volume (20 Days) | 173,616 |
Short Selling Information
The latest short interest is 682,030, so 1.88% of the outstanding shares have been sold short.
| Short Interest | 682,030 |
| Short Previous Month | 703,217 |
| Short % of Shares Out | 1.88% |
| Short % of Float | 4.46% |
| Short Ratio (days to cover) | 4.73 |
Income Statement
In the last 12 months, biote had revenue of $193.06 million and earned $7.19 million in profits. Earnings per share was $0.21.
| Revenue | 193.06M |
| Gross Profit | 135.23M |
| Operating Income | 39.94M |
| Pretax Income | 10.67M |
| Net Income | 7.19M |
| EBITDA | 40.78M |
| EBIT | 39.94M |
| Earnings Per Share (EPS) | $0.21 |
Full Income StatementBalance Sheet
The company has $38.23 million in cash and $122.31 million in debt, giving a net cash position of -$84.08 million or -$2.31 per share.
| Cash & Cash Equivalents | 38.23M |
| Total Debt | 122.31M |
| Net Cash | -84.08M |
| Net Cash Per Share | -$2.31 |
| Equity (Book Value) | -126.82M |
| Book Value Per Share | -4.19 |
| Working Capital | 23.47M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $39.83 million and capital expenditures -$4.60 million, giving a free cash flow of $35.23 million.
| Operating Cash Flow | 39.83M |
| Capital Expenditures | -4.60M |
| Free Cash Flow | 35.23M |
| FCF Per Share | $0.97 |
Full Cash Flow StatementMargins
Gross margin is 70.05%, with operating and profit margins of 20.69% and 3.72%.
| Gross Margin | 70.05% |
| Operating Margin | 20.69% |
| Pretax Margin | 5.99% |
| Profit Margin | 3.72% |
| EBITDA Margin | 21.13% |
| EBIT Margin | 20.69% |
| FCF Margin | 18.25% |
Dividends & Yields
biote does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -71.05% |
| Shareholder Yield | n/a |
| Earnings Yield | 4.63% |
| FCF Yield | 22.71% |
Analyst Forecast
The average price target for biote is $10.50, which is 140.28% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.50 |
| Price Target Difference | 140.28% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | 74.23% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
biote has an Altman Z-Score of 2.25 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.25 |
| Piotroski F-Score | 6 |